Development of radioresistance in drug resistant human MCF-7 breast cancer cells
- 1 December 2009
- journal article
- research article
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 8 (4), 207-213
- https://doi.org/10.1017/s1460396909990070
Abstract
Background and purpose: Radiotherapy is used for the treatment of malignant tumours, and may be used as the primary therapy. It is also common to combine radiotherapy with surgery, chemotherapy, hormone therapy or some combination of them. Even if the tumour is treated intensively, women diagnosed with breast cancer may develop a recurrence. Most recurrences may be in the form of distant metastases, development of multi-drug resistance phenotype or both together. This study demonstrated that some of the multi-drug resistant cancer cells may also become radioresistant.Materials and Methods: Chemoresistance in paclitaxel (MCF-7/Pac), docetaxel (MCF-7/Doc), vincristine (MCF-7/Vinc), doxorubicin (MCF-7/Dox) and zoledronic acid (MCF-7/Zol) resistant MCF-7 cells were demonstrated by XTT assay. MDR1 gene expression was detected by real-time PCR in human MCF-7 breast cancer cells. Drug resistant and sensitive cells were exposed to γ-radiation and development of radioresistance was investigated.Results: Results have indicated that paclitaxel, docetaxel, vincristine, doxorubicin and zoledronic acid–selected cells gained varying degrees of resistance to their selective drugs when compared with original MCF-7/S. MCF-7/Pac, MCF-7/Doc, MCF-7/Vinc and MCF-7/Dox cells have all acquired MDR1 expression. Among the resistant sub-lines, MCF-7/Pac and MCF-7/Doc cells were significantly cross-resistant to irradiation compared to the sensitive cells.Conclusion: MCF-7/Pac and MCF-7/Doc cell lines were found radioresistant to γ-radiation. On the contrary, doxorubicin, vincristine and zoledronic acid resistant cancer cells were still sensitive to radiation.Keywords
This publication has 25 references indexed in Scilit:
- Palliative Radiotherapy for Women with Breast CancerClinical Oncology, 2008
- Effect of Doxorubicin on Telomerase Activity and Apoptotic Gene Expression in Doxorubicin-Resistant and -Sensitive MCF-7 CellsChemotherapy, 2008
- Reversal of Multidrug Resistance by Synthetic and Natural Compounds in Drug-Resistant MCF-7 Cell LinesChemotherapy, 2008
- Radiation-induced effects on gene expression: An in vivo study on breast cancerRadiotherapy and Oncology, 2006
- The bisphosphonate zoledronic acid inhibits the development of plasmacytoma induced in BALB/c mice by intraperitoneal injection of pristaneEuropean Journal of Haematology, 2005
- Radioresistance in carcinoma of the breastThe Breast, 2004
- Bisphosphonates induce apoptosis in human breast cancer cell linesBritish Journal of Cancer, 2000
- A common pharmacophore for epothilone and taxanes: Molecular basis for drug resistance conferred by tubulin mutations in human cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2000
- Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesisInvestigational New Drugs, 1996
- Interaction of Vinca Alkaloids with Tubulin: A Comparison of Vinblastine, Vincristine, and VinorelbineBiochemistry, 1996